Core Viewpoint - SRx Health Solutions, Inc. has signed a non-binding Letter of Intent to acquire 100% of the assets of Royal Uranium Inc., enhancing its portfolio in the uranium royalty business and positioning itself to capitalize on the growing demand for nuclear energy and AI-related power needs [1][2]. Acquisition Details - The acquisition is subject to customary closing conditions, including the negotiation and execution of definitive transaction agreements [2]. - Post-acquisition, the company plans to adopt a new corporate name and ticker symbol to reflect its expanded mission [2]. Strategic Positioning - The acquisition will provide a diversified portfolio of 18 uranium royalties across key exploration and development projects in the Americas, offering long-term leverage to uranium as a commodity central to the global clean energy transition [3]. - Key partners in these royalties include major uranium operators such as Cameco, UEC, and Denison Mines, indicating strong industry relationships [3]. Market Demand Insights - Nuclear energy is increasingly favored by major tech companies for its reliable power supply and low carbon emissions, particularly for AI operations [4]. - The global data center power consumption is projected to increase by over 160% by 2030, with AI-related demand expected to add 200 TWh annually by the end of the decade, highlighting significant growth potential in energy demand [4]. Royalty Portfolio Highlights - The company will hold various royalties, including: - 1.0% NSR on the Berlin Project in Colombia - 2.0% NSR on Mountain Lake in Canada - 2.0% NSR on Laguna Salada in Argentina - Additional royalties across multiple Canadian projects [6].